Cargando…
AF.48 COMPARATIVE ASSESSMENT OF ADALIMUMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Autores principales: | Marsilio, I., Maniero, D., Lorenzon, G., Rigo, A., Cardin, R., Facchin, S., Barberio, B., D’Incà, R., Zingone, F., Bahur, B., Bray, K., Savarino, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editrice Gastroenterologica Italiana S.r.l.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451193/ http://dx.doi.org/10.1016/S1590-8658(21)00611-3 |
Ejemplares similares
-
AF.27 COVID-19 VACCINE: A SURVEY ON HESITANCY IN PATIENTS WITH CELIAC DISEASE
por: Costantino, A., et al.
Publicado: (2021) -
AF.51 VEDOLIZUMAB MAY BE AN EFFECTIVE OPTION FOR THE MANAGEMENT OF POSTOPERATIVE RECURRENCE OF CROHN’S DISEASE
por: Macaluso, F.S., et al.
Publicado: (2021) -
AF.78 THE PARADOX OF COVID-19 PANDEMIC: EFFECT OF LOCKDOWN ON THE IMPROVEMENT OF IRRITABLE BOWEL SYNDROME SEVERITY
por: Andreozzi, M., et al.
Publicado: (2021) -
AF.93 COVID-19 IN LIVER TRANSPLANT RECIPIENTS: AN ITALIAN CASE-CONTROL DOUBLE-CENTER STUDY
por: Guarino, M., et al.
Publicado: (2021) -
AF.42 SARS-COV-2 ANTIBODIES POSITIVITY IN IBD POPULATION AND CORRELATION WITH THERAPY: A PILOT STUDY
por: Conti, C.B., et al.
Publicado: (2021)